Focus. Together. For patients and society.
IPSEN IN GREECE
Our presence in Greece dates back to 1979. Our offices are located in a green area, along with other pharmaceutical companies, in a neighborhood of Athens known as Alimos. Ipsen Greece is also responsible for Cyprus and Malta. Οur overarching goal is the optimization of health and quality of life for patients in the therapeutic areas of oncology, neuroscience and rare diseases.
ABOUT IPSEN
Founded in 1929 as a family business, Ipsen Group has almost a century of experience and expertise and focuses in three therapeutic areas: oncology, rare disease and neuroscience. Our team works together every day to innovate for the benefit of patients and caregivers.
Making an impact
Our purpose-led people are passionate about making a real impact on patients’ lives every day. We do this by striving to discover, innovate and bring to market pharmaceutical products that will make a difference in the lives of patients, their caregivers and healthcare professionals.
Leading the way
With a focus on transformative medicines in oncology, rare disease and neuroscience and with the right combination of size and agility, we continue to push ourselves as a business and as individuals to deliver positive change.
Our strategy
Our strategy, Focus. Together. For patients & society, consists of four strategic priorities that guide our decision-making.
We are focused on ensuring patients have access to our treatments, collaborating with them and with patient organizations to unlock key insights that will allow us to deliver advancements. We work tirelessly to ensure patients have access to our innovative treatments.
We’re committed to building a robust, sustainable pipeline across all stages of development and in each of our three therapy areas so that we can continue to deliver innovative treatments, now and in the future. We seek out biotechs, academic institutions and other partners who share our vision of making a real impact for patients, and we aim to deliver at least one molecular entity or meaningful indication every year.
We focus our efforts and resources where they will move the needle for patients. By creating efficiencies, we can make the right investments at the right time to bring new, innovative therapies to patients around the world.
Our team of talented and dedicated professionals around the world endeavors every day to develop and build our capabilities. With our science-led and patient-driven approach, we grow together in a supportive environment.
Our ESG commitment
Our mission is clear: to prolong and improve patients’ lives and health outcomes and make a positive impact for society. Our ESG framework guides us as we deliver positive change across four key areas: Environment, Patients, People and Governance.
Our global presence
Ipsen’s products are registered in 88 countries. With professionals, working to create value for patients and society around the world, we have global reach while remaining an agile, mid-sized company.
